Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Blood

• Publication date

  2009-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2008-02-136903PMID 18845794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of EBV on the Peripheral Blood Memory B Cell Compartment1

  2007cited by this paper
• A Molecular Link between Malaria and Epstein–Barr Virus Reactivation

  2007cited by this paper
• Duration of humoral immunity to common viral and vaccine antigens.

  2007cited by this paper
• Pathogens cooperate in lymphomagenesis

  2007cited by this paper
• AIDS-related lymphoproliferative disease.

  2006cited by this paper
• Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay.

  2006cited by this paper
• Epstein-Barr Virus BZLF1 Gene, a Switch from Latency to Lytic Infection, Is Expressed as an Immediate-Early Gene after Primary Infection of B Lymphocytes

  2006cited by this paper
• Detection of a large T-cell reservoir able to replicate HIV-1 actively in breast milk

  2006cited by this paper
• Peripheral Blood Naive and Memory B Cells

  2005cited by this paper
• Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo

  2005cited by this paper
• Epstein-Barr-Virus-Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis

  2005cited by this paper
• Mutation of a Single Amino Acid Residue in the Basic Region of the Epstein-Barr Virus (EBV) Lytic Cycle Switch Protein Zta (BZLF1) Prevents Reactivation of EBV from Latency

  2005cited by this paper
• Measuring immunity :basic biology and clinical assessment

  2005cited by this paper
• Human Immunodeficiency Virus Type 1 (HIV-1) Antigen Secretion by Latently Infected Resting CD4+ T Lymphocytes from HIV-1-Infected Individuals

  2004cited by this paper
• Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.

  2004cited by this paper
• Human Immunodeficiency Virus Type 1 (HIV-1) Antigen Secretion by Latently Infected Resting CD4+ T Lymphocytes from HIV-1-Infected Individuals

  2004cited by this paper
• Surface Immunoglobulin-Deficient Epstein-Barr Virus-Infected B Cells in the Peripheral Blood of Pediatric Solid-Organ Transplant Recipients

  2004cited by this paper
• Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo

  2003cited by this paper
• Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy

  2003cited by this paper
• Routine use of real‐time quantitative PCR for laboratory diagnosis of Epstein‐Barr virus infections

  2002cited by this paper
• Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies.

  2002cited by this paper
• Detection of Epstein-Barr Virus Genomes in Peripheral Blood B Cells from Solid-Organ Transplant Recipients by Fluorescence In Situ Hybridization

  2002cited by this paper
• Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive Tumors

  2002cited by this paper
• Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients.

  2001cited by this paper
• Epstein-Barr virus: exploiting the immune system

  2001cited by this paper
• Loss of memory (CD27) B lymphocytes in HIV-1 infection

  2001cited by this paper
• CD27: a memory B-cell marker.

  2000cited by this paper
• Spontaneous monoclonal immunoglobulin‐secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma

  2000cited by this paper
• Detection and enumeration of HIV-1-producing cells by ELISPOT (enzyme-linked immunospot) assay.

  1999cited by this paper
• Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients

  1999cited by this paper
• Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells

  1998cited by this paper
• Non-correlation of in vivo and in vitro parameters of Epstein-Barr virus persistence suggests heterogeneity of B cell infection.

  1998cited by this paper
• Relation of Burkitt's tumor‐associated herpes‐type virus to infectious mononucleosis

  1998cited by this paper
• Impairment of B‐lymphocyte differentiation induced by dual triggering of the B‐cell antigen receptor and CD40 in advanced HIV‐1‐disease

  1998cited by this paper
• EBV persistence in memory B cells in vivo.

  1998cited by this paper
• Immunology: Burnet's unhappy hybrid

  1998cited by this paper
• Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state.

  1997cited by this paper
• The changing preference of T and B cells for partners as T‐dependent antibody responses develop

  1997cited by this paper
• Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

  1997cited by this paper
• B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production

  1997cited by this paper
• Epstein-Barr virus and its replication

  1996cited by this paper
• YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter

  1995cited by this paper
• Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1

  1995cited by this paper
• Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells.

  1994cited by this paper
• The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B

  1994cited by this paper
• RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism

  1994cited by this paper
• Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1.

  1994cited by this paper
• IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset.

  1992cited by this paper
• Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA.

  1992cited by this paper
• Human B lymphocytes: phenotype, proliferation, and differentiation.

  1992cited by this paper
• Pathways of activation of the Epstein-Barr virus productive cycle

  1991cited by this paper
• CD27 expression by a distinct subpopulation of human B lymphocytes

  1990cited by this paper
• Synchronous and sequential activation of latently infected Epstein-Barr virus genomes

  1989cited by this paper
• Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells.

  1988cited by this paper
• An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200)

  1984cited by this paper
• A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.

  1983cited by this paper
• A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.

  1983cited by this paper
• Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: Origin of transformed cells arising in co‐cultures with foetal lymphocytes

  1977cited by this paper
• Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals.

  1973cited by this paper
• Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

  1968cited by this paper

• Does Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Represent a Poly-Herpesvirus Post-Virus Infectious Disease?

  2025cites this paper
• Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada

  2024cites this paper
• EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies

  2023cites this paper
• Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1 reactivation in ME/CFS and long COVID

  2023cites this paper
• The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities

  2023cites this paper
• Epstein−Barr virus reactivation induces MYC‐IGH spatial proximity and t(8;14) in B cells

  2023cites this paper
• B Cell Receptor-Responsive miR-141 Enhances Epstein-Barr Virus Lytic Cycle via FOXO3 Inhibition

  2021cites this paper
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!

  2021cites this paper
• Potential effect of epigenetic drugs in the treatment of multiple-site extramedullary plasmacytoma involving the respiratory system: a case report and review of the literature

  2021cites this paper
• Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus

  2020cites this paper
• Oncogenic Properties of the EBV ZEBRA Protein

  2020cites this paper
• A tissue level atlas of the healthy human virome

  2020cites this paper
• Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report

  2020cites this paper
• B Cell Receptor-Responsive miR-141 and viral miR-BART9 promote Epstein-Barr Virus Reactivation Through FOXO3 Inhibition

  2019cites this paper
• Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome

  2019cites this paper
• Multiparametric flow cytometry analysis of peripheral blood B cell trafficking differences among Epstein-Barr virus infected and uninfected subpopulations.

  2019cites this paper
• Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans

  2018cites this paper
• Investigation of the adaptive immune response in multiple sclerosis

  2018cites this paper
• The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis

  2018cites this paper
• EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies

  2018cites this paper
• CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity

  2018cites this paper
• Analyse de la charge virale Epstein Barr chez les patients atteints de parodontite chronique : traitement parodontal et réponse virale

  2017cites this paper
• Séquençage du génome complet du virus d’Epstein-Barr dans des prélèvements issus de lymphomes T angio-immunoblastiques

  2017cites this paper
• Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD

  2017cites this paper
• Epigenetic Alterations of Viral and Cellular Genomes in EBV-Infected Cells

  2016cites this paper
• Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease

  2016cites this paper
• Circulating FVIII‐specific IgG, IgA and IgM memory B cells from haemophilia A patients

  2016cites this paper
• Epstein-Barr Virus (EBV) Encoded Dutpase Exacerbates the Immune pathology of Lupus Nephritis In Vivo

  2016cites this paper
• ebv dutpase modulates host immune responses potentially altering the tumor microenvironment in ebv associated malignancies

  2016cites this paper
• Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

  2015cites this paper
• Close relationship between immunoglobulin secreting‐cells and Epstein–Barr virus reservoir in patients infected with HIV

  2014cites this paper
• Human herpesviruses-encoded dUTPases: a family of proteins that modulate dendritic cell function and innate immunity

  2014cites this paper
• Comparison of EBV DNA viral load in whole blood, plasma, B‐cells and B‐cell culture supernatant

  2014cites this paper
• Epstein–Barr Virus (EBV) MicroRNAs: Involvement in Cancer Pathogenesis and Immunopathology

  2013cites this paper
• Epstein–Barr virus infection transforms CD25+ B cells into antibody‐secreting cells in rheumatoid arthritis patients

  2013cites this paper
• Epstein–Barr Virus Infection Induces Aberrant TLR Activation Pathway and Fibroblast–Myofibroblast Conversion in Scleroderma

  2013cites this paper
• Epstein-Barr Virus Encoded dUTPase Containing Exosomes Modulate Innate and Adaptive Immune Responses in Human Dendritic Cells and Peripheral Blood Mononuclear Cells

  2013cites this paper
• Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy.

  2013cites this paper
• Large-Scale In Vitro Expansion of Polyclonal Human Switched-Memory B Lymphocytes

  2012cites this paper
• The EBV-HIV interrelationship and the value of EBV-DNA analysis

  2012cites this paper
• Increased T-Cell Activation and Th1 Cytokine Concentrations Prior to the Diagnosis of B-Cell Lymphoma in HIV Infected Patients

  2012cites this paper
• Libération extra-cellulaire de microARN et de complexes nucléo-protéiques par les cellules infectées par EBV : rôle des exosomes et d’autres transporteurs

  2011cites this paper
• B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.

  2011cites this paper
• RNA transfer by Epstein-Barr virus triggers early events that regulate cell fate and promote immune evasion

  2011cites this paper
• Inhibition du cycle lytique du Virus Epstein-Barr par ARN interférence

  2010cites this paper
• Investigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccination.

  2010cites this paper
• Downregulation of RUNX1 by RUNX3 Requires the RUNX3 VWRPY Sequence and Is Essential for Epstein-Barr Virus-Driven B-Cell Proliferation

  2009cites this paper